pharmaceutical regulation – The Milli Chronicle

Thursday, January 1, 2026

Latest:

Myanmar Election Process Moves Forward as First Phase Records 52% Voter Participation
Philippines Reaffirms Maritime Vigilance and Regional Stability in Northern Waters
China’s Biren Technology Secures Landmark Hong Kong IPO Boosting AI Chip Ambitions
Nvidia Explores Expanded H200 Chip Production as Asian AI Demand Accelerates
India Introduces Revised Excise Duty on Cigarettes to Strengthen Public Health Policy

Factual Version of a Story

NewsDesk Milli Chronicle January 1, 2026 branded medicines market, cancer drug market, diabetes medication pricing, drug affordability debate, drug pricing reform, drugmaker pricing strategy, healthcare innovation, healthcare policy US, inflation and drug prices, medical research investment, medicine pricing updates, patient access medicines, pharmaceutical industry, pharmaceutical regulation, pharmaceutical trends 2026, prescription drugs USA, US drug prices, US healthcare economy, US medicine costs, vaccine pricing news

Drugmakers Adjust US Medicine Prices While Expanding Innovation and Access Efforts

Measured price updates across select medicines highlight the pharmaceutical industry’s balancing act between affordability, innovation, and long-term investment in patient

US FDA’s Drug Division Undergoes Leadership Transition to Strengthen Integrity and Innovation

The U.S. Food and Drug Administration begins a new chapter in its drug evaluation and research division, focusing on ethics,